A Leader in Real-World Data
Our SoleMetrics® proprietary clinical outcomes program delivers real-world evidence to clients. SoleMetrics has the distinct ability to collect and share disease, drug and de-identified patient-specific data over time to gather intelligent outcomes throughout the patients’ journeys.
To request a copy of any of our clinical abstracts or case studies below, please fill out the following form.
Case Study - Successful prophylactic use of coagulation factor X in an infant patient in the home environment
Development of a Specialty Infusion Pharmacy Clinical Monitoring Model for Patients with Adult and Pediatric Dermatopolymyositis Receiving Immunoglobulin Therapy
Development of a Specialty Infusion Pharmacy Clinical Monitoring Model for Patients with Myasthenia Gravis Receiving First-In-Class Therapy Efgartigimod
Home Infusion Administration and Clinical Monitoring Experience of Teprotumumab-trbw in Thyroid Eye Disease (TED) Patients by a Home Infusion Specialty Provider
Identifying Trends in the Use of Immunoglobulin Therapy in Patients with a History of Transplant
Management of home total parenteral nutrition (TPN) therapy for a patient with enteroatmospheric fistulas- Therapy adherence intervention leads to positive patient outcomes
Real-World Evidence of Radicava® (edaravone) for Amyotrophic Lateral Sclerosis From a National Infusion Center Database in the United States
Real-World Treatment Patterns in Amyotrophic Lateral Sclerosis Patients Treated With IV Edaravone - 12-Months of Follow-up in Patients Receiving Treatment From a National Infusion Center
Role of the Pharmacist in Monitoring Oral Edaravone
Therapy optimization and clinical interventions within a specialty infusion pharmacy lead to significant direct and indirect cost savings
Use of Immunoglobulin (Ig) Therapy for Stiff-Person Syndrome (SPS) within a Specialty Infusion Pharmacy